BlackRock Group LTD - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 177 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Group LTD ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$5,751,000
+280.4%
582,094
+364.9%
0.00%
+200.0%
Q3 2016$1,512,000
+36.7%
125,196
-2.3%
0.00%0.0%
Q2 2016$1,106,000
-9.4%
128,116
-0.6%
0.00%0.0%
Q1 2016$1,221,000
-39.3%
128,945
+11.2%
0.00%0.0%
Q4 2015$2,010,000
+64.1%
115,989
+27.1%
0.00%0.0%
Q3 2015$1,225,000
-36.2%
91,246
+7.4%
0.00%0.0%
Q2 2015$1,919,000
+72.1%
84,970
+8.8%
0.00%0.0%
Q1 2015$1,115,000
+82.2%
78,068
+23.2%
0.00%
Q4 2014$612,000
+36.9%
63,379
+29.1%
0.00%
Q3 2014$447,000
-8.8%
49,100
-1.1%
0.00%
Q2 2014$490,000
-61.1%
49,652
-50.0%
0.00%
-100.0%
Q1 2014$1,261,000
-1.9%
99,213
+15.6%
0.00%0.0%
Q4 2013$1,286,000
+49.9%
85,827
+10.5%
0.00%0.0%
Q3 2013$858,000
-16.7%
77,662
-40.0%
0.00%0.0%
Q2 2013$1,030,000129,4760.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Third Security, LLC 19,829,337$266,308,00010.60%
BB BIOTECH AG 6,929,832$93,068,0002.95%
SECTORAL ASSET MANAGEMENT INC 2,671,051$35,872,0001.64%
Sterling Global Strategies LLC 22,000$295,0001.63%
Lombard Odier Asset Management (USA) Corp 1,061,547$14,257,0001.24%
PYRRHO CAPITAL MANAGEMENT, LP 90,000$1,209,0001.04%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,184,003$109,911,0000.93%
Bellevue Asset Management AG 246,000$3,304,0000.54%
Convergence Investment Partners, LLC 251,748$3,381,0000.39%
Rhenman & Partners Asset Management AB 172,000$2,310,0000.37%
View complete list of HALOZYME THERAPEUTICS INC shareholders